WEBULL

3 Global Penny Stocks With Market Caps Under US$2B

Simply Wall St · 05/01/2025 09:05

Global markets have shown signs of optimism as trade tensions between major economies appear to be easing, with U.S. stocks rising on positive trade headlines and corporate earnings surpassing expectations. Amid these developments, investors often look beyond the large-cap giants to explore opportunities in smaller companies that can offer unique growth prospects. Penny stocks, although an older term, still represent a viable investment area for those seeking potential high returns through financially sound companies that may not yet be on the radar of most market participants.

Top 10 Penny Stocks Globally

Name Share Price Market Cap Rewards & Risks
CNMC Goldmine Holdings (Catalist:5TP) SGD0.42 SGD170.22M ✅ 4 ⚠️ 3 View Analysis >
Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.23 SGD8.78B ✅ 5 ⚠️ 0 View Analysis >
Angler Gaming (NGM:ANGL) SEK3.76 SEK281.94M ✅ 4 ⚠️ 3 View Analysis >
SKP Resources Bhd (KLSE:SKPRES) MYR0.89 MYR1.39B ✅ 5 ⚠️ 1 View Analysis >
NEXG Berhad (KLSE:NEXG) MYR0.345 MYR1B ✅ 4 ⚠️ 3 View Analysis >
Lever Style (SEHK:1346) HK$1.06 HK$668.81M ✅ 4 ⚠️ 2 View Analysis >
Goodbaby International Holdings (SEHK:1086) HK$1.11 HK$1.85B ✅ 4 ⚠️ 2 View Analysis >
Foresight Group Holdings (LSE:FSG) £3.71 £419.25M ✅ 4 ⚠️ 1 View Analysis >
QinetiQ Group (LSE:QQ.) £3.926 £2.16B ✅ 5 ⚠️ 1 View Analysis >
EZZ Life Science Holdings (ASX:EZZ) A$1.37 A$66.75M ✅ 4 ⚠️ 2 View Analysis >

Click here to see the full list of 5,635 stocks from our Global Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Oiltek International (Catalist:HQU)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Oiltek International Limited is an investment holding company involved in supplying and providing engineering design and commissioning of oil extraction equipment and plants across Asia, America, and Africa, with a market cap of SGD200.20 million.

Operations: Oiltek International's revenue is primarily derived from its Edible & Non-Edible Oil Refinery segment, contributing MYR193.87 million, followed by Product Sales and Trading at MYR18.78 million and Renewable Energy at MYR17.65 million.

Market Cap: SGD200.2M

Oiltek International has demonstrated robust financial health with no debt and a strong balance sheet, where short-term assets of MYR212.5 million comfortably cover liabilities. Recent contract wins worth MYR61.9 million across multiple regions bolster its order book to approximately MYR402.4 million, potentially enhancing future revenue streams. The company reported sales of MYR230.29 million for 2024, with net income rising to MYR29.64 million, reflecting improved profit margins from 9.5% to 12.9%. Despite high earnings growth of 55% last year and a solid return on equity at 35.2%, the stock remains highly volatile in the market.

Catalist:HQU Revenue & Expenses Breakdown as at May 2025
Catalist:HQU Revenue & Expenses Breakdown as at May 2025

Tianjin Chase Sun PharmaceuticalLtd (SZSE:300026)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Tianjin Chase Sun Pharmaceutical Co., Ltd is involved in the research, development, production, and sale of pharmaceutical products both in China and internationally, with a market cap of CN¥10.15 billion.

Operations: No specific revenue segments are reported for Tianjin Chase Sun Pharmaceutical Co., Ltd.

Market Cap: CN¥10.15B

Tianjin Chase Sun Pharmaceutical Ltd. presents a mixed financial picture with stable weekly volatility at 5% over the past year but declining earnings, having decreased by 93.9% recently. Despite this, the company maintains a strong balance sheet, with short-term assets of CN¥6.1 billion exceeding both long-term and short-term liabilities significantly. The company's debt is well covered by operating cash flow at 140.4%, and it has more cash than total debt, reflecting prudent financial management. However, profit margins have contracted to 0.4%, down from last year's 6.6%, indicating profitability challenges amidst competitive pressures in the pharmaceutical industry.

SZSE:300026 Debt to Equity History and Analysis as at May 2025
SZSE:300026 Debt to Equity History and Analysis as at May 2025

Beijing Baination PicturesLtd (SZSE:300291)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Beijing Baination Pictures Co., Ltd. is a film and television company based in China with a market capitalization of CN¥4.48 billion.

Operations: No revenue segments are reported for this film and television company based in China.

Market Cap: CN¥4.48B

Beijing Baination Pictures Co., Ltd. exhibits a complex financial landscape with recent revenue growth to CN¥738.56 million, yet remains unprofitable, posting a net loss of CN¥393.12 million for 2024. Despite this, the company holds more cash than its total debt and boasts short-term assets of CN¥3.2 billion surpassing both short- and long-term liabilities significantly, suggesting robust liquidity management. Shareholders have not faced significant dilution recently, and the experienced board could provide strategic stability amid high share price volatility over the past three months. The company's cash runway extends beyond three years under current conditions.

SZSE:300291 Debt to Equity History and Analysis as at May 2025
SZSE:300291 Debt to Equity History and Analysis as at May 2025

Key Takeaways

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.